KNSA - Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A
IEX Last Trade
26.75
-0.010 -0.037%
Share volume: 227,263
Last Updated: Fri 30 Aug 2024 09:59:54 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$26.76
-0.01
-0.04%
Summary score
9%
Profitability
2%
Dept financing
4%
Liquidity
71%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-5.26%
Return on assets
-7.04%
Return on sales
-93.74%
Return on invested capital
-2234.72%
Total debt ratio
15.73%
Debt ratio change over timeo
-0.75%
Current Ratio
6.61%
Quick Ratio
5.89%
Cash Position Ratio
5.44%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0.47%
Return on assets
-1.52%
Return on sales
-10.33%
Return on invested capital
0.96%
Total debt ratio
16.16%
Debt ratio change over timeo
-1.61%
Current Ratio
4.63%
Quick Ratio
4.16%
Cash Position Ratio
3.56%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-4.1%
Return on assets
-3.18%
Return on sales
-20.71%
Return on invested capital
-9.58%
Total debt ratio
16.89%
Debt ratio change over time
0.25%
Current Ratio
4.21%
Quick Ratio
3.79%
Cash Position Ratio
3.33%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
29.42%
Return on assets
-81.09%
Return on sales
-7.28%
Return on invested capital
-26.8%
Total debt ratio
-75.07%
Debt ratio change over time
-0.75%
Current Ratio
6.25%
Quick Ratio
6.25%
Cash Position Ratio
5.42%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | KNSA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -5.26% | 13.79% | 34.47% | 7.43% |
| Return on assets | -7.04% | 2.76% | 3.15% | 5.62% |
| Return on sales | -93.74% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -2234.72% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 15.73% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.75% | 308.97% | -6.99% | 1.18% |
| Dept financing | 4% | 50% | 25% | 7% |
| Current Ratio | 4.63% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 4.16% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.56% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 8% | 18% | 42% |
| Short-term ratios | KNSA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 0.47% | 13.77% | 13.25% | 3.8% |
| Return on assets | -1.52% | 2.43% | 1.89% | 3.09% |
| Return on sales | -10.33% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 0.96% | 2.14% | 3.39% | 9.18% |
| Profitability | 3% | 71% | 68% | 82% |
| Total debt ratio | 16.16% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -1.61% | 46.38% | -72.08% | 1.51% |
| Dept financing | 4% | 50% | 25% | 7% |
| Current Ratio | 4.63% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 4.16% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.56% | 0.36% | 1.28% | 2.93% |
| Liquididy | 69% | 11% | 29% | 71% |